Skip to main content

Contact Hiroshi Aikata

From: Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

Contact corresponding author
\